Skip to main content
Fig. 2 | Trials

Fig. 2

From: The efficacy of micropulse laser combined with ranibizumab in diabetic macular edema treatment: study protocol for a randomized controlled trial

Fig. 2

Assessment protocol from V1 to V14. BSL Base line, EOT End of treatment, EOS End of study. (X): Give treatment as needed. b: Except at the time of screening, at month 6 and at month 12 / end of the study, if the investigator needed information to evaluate the retreatment. These assessments are optional for therapeutic needs. c: Evaluation of both eyes. d: At 2 (±1) days after each study treatment, the investigator should contact the patient for a possible report of adverse events

Back to article page

Trials

ISSN: 1745-6215